NOLLECA FORBES: Open Payments
NPI 1962828152 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 16 payments from 7 companies in 2025. Trend: 2023 $566 · 2024 $188 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $413 |
| Teva Pharmaceuticals USA, Inc. | 4 | $144 |
| ABBVIE INC. | 4 | $68 |
| AtriCure, Inc. | 1 | $45 |
| ABIOMED | 1 | $29 |
| Alkermes, Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $17 |
Products named: SAPIEN 3 Ultra RESILIA, UZEDY, VRAYLAR, ATRICLIP LAA EXCLUSION SYSTEM, VIVITROL, AUSTEDO XR, COREVALVE EVOLUT R.
Industry payments across NJ — which companies pay providers there.
